Agilent Technologies Inc (A)
136.01
-1.48
(-1.08%)
USD |
NYSE |
Apr 25, 13:36
Agilent Technologies Research and Development Expense (Quarterly): 128.00M for Jan. 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| January 31, 2024 | 128.00M |
| October 31, 2023 | 114.00M |
| July 31, 2023 | 118.00M |
| April 30, 2023 | 126.00M |
| January 31, 2023 | 123.00M |
| October 31, 2022 | 119.00M |
| July 31, 2022 | 116.00M |
| April 30, 2022 | 115.00M |
| January 31, 2022 | 117.00M |
| October 31, 2021 | 116.00M |
| July 31, 2021 | 113.00M |
| April 30, 2021 | 109.00M |
| January 31, 2021 | 103.00M |
| October 31, 2020 | 102.00M |
| July 31, 2020 | 92.00M |
| April 30, 2020 | 197.00M |
| January 31, 2020 | 104.00M |
| October 31, 2019 | 102.00M |
| July 31, 2019 | 101.00M |
| April 30, 2019 | 99.00M |
| January 31, 2019 | 102.00M |
| October 31, 2018 | 104.00M |
| July 31, 2018 | 97.00M |
| April 30, 2018 | 92.00M |
| January 31, 2018 | 94.00M |
| Date | Value |
|---|---|
| October 31, 2017 | 91.00M |
| July 31, 2017 | 87.00M |
| April 30, 2017 | 84.00M |
| January 31, 2017 | 79.00M |
| October 31, 2016 | 84.00M |
| July 31, 2016 | 86.00M |
| April 30, 2016 | 81.00M |
| January 31, 2016 | 78.00M |
| October 31, 2015 | 82.00M |
| July 31, 2015 | 79.00M |
| April 30, 2015 | 81.00M |
| January 31, 2015 | 88.00M |
| October 31, 2014 | 97.00M |
| July 31, 2014 | 86.00M |
| April 30, 2014 | 87.00M |
| January 31, 2014 | 88.00M |
| October 31, 2013 | -194.00M |
| July 31, 2013 | 171.00M |
| April 30, 2013 | 181.00M |
| January 31, 2013 | 179.00M |
| October 31, 2012 | 178.00M |
| July 31, 2012 | 162.00M |
| April 30, 2012 | 166.00M |
| January 31, 2012 | 162.00M |
| October 31, 2011 | 163.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
92.00M
Minimum
Jul 2020
197.00M
Maximum
Apr 2020
115.70M
Average
114.50M
Median
Research and Development Expense (Quarterly) Benchmarks
| Bio-Rad Laboratories Inc | 63.90M |
| Revvity Inc | 49.60M |
| Bruker Corp | 83.50M |
| Azenta Inc | 8.493M |
| Harvard Bioscience Inc | 3.15M |